Microwave Ablation of Uterine Fibroids

Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)

Overview

Key facts that identify this study and show where it stands today.

What the study is about and why it is being run, in the researchers' own words.

Official Title: Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)
Brief Summary: This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment or symptomatic uterine fibroids. We will include 100 women.

The medical conditions and diseases this study investigates.

The treatments and procedures being evaluated in this study.

Who can join this study and the criteria used to decide.

Ages Eligible for Study: Adult (18-64)
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Eligibility Criteria: Inclusion Criteria:

symptomatic fibroids

premenopausal status

acceptable risks for general anestesia or sedation

willing to undergo mwa treatment and participate in the study

Exclusion Criteria:

postmenopausal status

bleeding disorder with increased risk of bleeding

How the study is designed and how its participant groups are organized.

The people to reach with questions about this study or how to join it.

No central contacts

There are no central contacts for this study.

Where the study is run and whether each site is currently recruiting.

Turku University Hospital

Turku, Finland

The organizations and people involved in this study.

Other registered studies that closely resemble this one.